Macrophages target PVR/CD155 on colorectal cancer cells via REVERBalpha
Dominik Kato, Yu Han, Laura Helm, Frank Herweck, Natalia Schichta, Lennart Malz, Katharina Herrmann, Mohammad Saad Farooq, Veronika Hauber, Tobias Gutting, Johannes Betge, Carsten Sticht, Timo Gaiser, Adelheid Cerwenka, Matthias P. A. Ebert, Elke Burgermeister
This study shows that macrophages target PVR/CD155 on colorectal cancer cells via REVERBα, suggesting a new therapeutic strategy for MSS+ CRC.
bioRxiv · Jan 29, 2026 · PreprintCancer Biology